Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -7.86 | -23.37 |
PEG Ratio (TTM) | -22.95 | -7.10 |
P/S Ratio (TTM) | 23.99 | 44.34 |
P/B Ratio (TTM) | 3.69 | 33.03 |
P/FCF Ratio (TTM) | -12.10 | -7.73 |
Price to 5YR AVG Earnings Ratio | -7.89 | -7.08 |
Price to 5YR AVG FCF Ratio | -18.93 | -13.02 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -34.46% | -15.67% |
ROE (TTM) | -63.39% | 27.44% |
Net Profit Margin (TTM) | -313.65% | -627.99% |
ROIC 5YR AVG | -69.67% | -4.84% |
Growth (12%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 0.07% | -128.90% | -77.89% |
Revenue | -7.87% | 2.44% | 27.29% |
Net Income | -7.40% | -133.49% | -85.77% |
Cash Flow | -35.22% | -35,122.56% | -21,081.60% |
Health (53%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.28 | 5.66 |
Quick Ratio (TTM) | 5.28 | 5.44 |
D/E Ratio (TTM) | 0.02 | 1.19 |
Interest Coverage (TTM) | -24.56 | -5.92 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | 4.03 | 13.21 |
LTL to 5YR AVG FCF | -0.32 | 0.09 |
Shares Outstanding Growth 5YR AVG | 56.06% | 39.51% |